Pfizer has reported positive outcomes from the Phase III BREAKWATER trial of BRAFTOVI plus cetuximab and mFOLFOX6 for ...

Intellia Therapeutics has dosed the first subject in the Phase III trial of NTLA-2002, to treat hereditary angioedema (HAE).

Mayo Clinic has joined SeaStar Medical as the 15th site authorised to enrol subjects for the company’s pivotal NEUTRALIZE-AKI ...

Amgen’s LUMAKRAS and Vectibix combination has received approval from the US FDA for treating KRAS G12C-mutated mCRC.

Four million Australian households and businesses have rooftop solar installed, making us the world leader in the technology.

Three decades on from a moment of madness that shook English football, Telegraph Sport speaks to those who were a part of it ...

PEOPLE understands that News Group Newspapers (NGN) has agreed to pay the Duke of Sussex an eight-figure sum in his case ...

Two men and a woman were taken into custody following the incident at a Michigan home on Saturday, Jan. 25, according to ...

Shutterstock CEO Paul Hennessy said the merger with Getty Images provides an opportunity to "meet diverse customer needs.” ...

Executives from Butterfly Equity and The Duckhorn Portfolio on how they plan to grow the business and their thoughts on the ...